Gen-Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Sell
817
-51
-6% -$52.1K 0.27% 81
2026
Q1
$798K Sell
868
-15
-2% -$15.2K 0.25% 82
2025
Q4
$949K Sell
883
-71
-7% -$67.9K 0.3% 68
2025
Q3
$728K Buy
954
+700
+276% +$521K 0.25% 102
2025
Q2
$198K Hold
254
0.08% 220
2025
Q1
$210K Sell
254
-12
-5% -$9.98K 0.09% 203
2024
Q4
$205K Buy
266
+2
+0.8% +$1.66K 0.09% 210
2024
Q3
$224K Sell
264
-80
-23% -$71.9K 0.1% 206
2024
Q2
$311K Buy
344
+91
+36% +$72.8K 0.15% 160
2024
Q1
$197K Buy
+253
New +$180K 0.1% 202

Other funds holding LLY

Gen-Wealth Partners's LLY Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Eli Lilly (LLY) stake by 5.9% in Q2 2026, selling an estimated $52.1K and leaving 817 shares worth $980K. The position accounts for 0.27% of the portfolio, ranked #81.

Gen-Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gen-Wealth Partners held 817 shares of Eli Lilly worth $980K as of Q2 2026.
  • Gen-Wealth Partners sold 51 Eli Lilly shares in Q2 2026, an estimated $52.1K.
  • Eli Lilly made up 0.27% of Gen-Wealth Partners's portfolio in Q2 2026, its #81 holding.
  • Gen-Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.